Version 1
: Received: 17 January 2018 / Approved: 18 January 2018 / Online: 18 January 2018 (05:12:13 CET)
How to cite:
Shahbazi-Gahrouei, D.; Moradi Khaniabadi, P.; Moradi khaniabadi, B.; Shahbazi-Gahrouei, S.; Fazel, M. Molecular imaging modalities using nanoprobes for cancer diagnosis. Preprints2018, 2018010167. https://doi.org/10.20944/preprints201801.0167.v1
Shahbazi-Gahrouei, D.; Moradi Khaniabadi, P.; Moradi khaniabadi, B.; Shahbazi-Gahrouei, S.; Fazel, M. Molecular imaging modalities using nanoprobes for cancer diagnosis. Preprints 2018, 2018010167. https://doi.org/10.20944/preprints201801.0167.v1
Shahbazi-Gahrouei, D.; Moradi Khaniabadi, P.; Moradi khaniabadi, B.; Shahbazi-Gahrouei, S.; Fazel, M. Molecular imaging modalities using nanoprobes for cancer diagnosis. Preprints2018, 2018010167. https://doi.org/10.20944/preprints201801.0167.v1
APA Style
Shahbazi-Gahrouei, D., Moradi Khaniabadi, P., Moradi khaniabadi, B., Shahbazi-Gahrouei, S., & Fazel, M. (2018). Molecular imaging modalities using nanoprobes for cancer diagnosis. Preprints. https://doi.org/10.20944/preprints201801.0167.v1
Chicago/Turabian Style
Shahbazi-Gahrouei, D., Saghar Shahbazi-Gahrouei and Mona Fazel. 2018 "Molecular imaging modalities using nanoprobes for cancer diagnosis" Preprints. https://doi.org/10.20944/preprints201801.0167.v1
Abstract
Molecular imaging modalities are used for different type of cancers detection and diagnosis. In recent few years, there has been an increased focus on developing novel nanoparticles as new imaging contrast agents for early detection of cancer. The aim of this review article is to summarize molecular imaging technologies accompanying with using nanoparticles to improve potential imaging for cancer detection and hence valuable therapy in the future. Nanoprobes are rapidly becoming potentially transformative tools on cancer diagnostics for a wide range of imaging modalities such as CT, MRI, SPECT, PET, Ultrasound and Optical imaging. The study results seen in the recent literature are provided and discussed the diagnostic performance of imaging modalities for cancer diagnosis and their future directions. With knowledge of the correlation between the application of nanoparticles and molecular imaging modalities and with the development of targeted contrast agents or nanoprobes, they may provide better cancer diagnosis in the future.
Keywords
molecular imaging; nanoparticles; cancer diagnosis; imaging modalities
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
